SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
Background: The aim of this paper is to assess the impact of sodium-glucose cotransporters-2 (SGLT2) inhibitors on all-cause and cardiovascular (CV) death in high-risk patients and compare the efficacy of empagliflozin and dapagliflozin. Methods: PubMed was queried from inception to the last week...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
PAGEPress Publications
2023-11-01
|
| Seria: | Global Cardiology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.globalcardiology.info/site/article/view/2 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|